Dr. Schacknow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
509 SE Riverside Dr
Ste 302
Stuart, FL 34994Phone+1 772-287-9000Fax+1 772-287-0507
Summary
- Paul Schacknow, MD, is an ophthalmologist based in Stuart, Florida, with a subspecialty focus on glaucoma-related disorders. He completed his medical education at the University of Miami Leonard M. Miller School of Medicine, followed by an Ophthalmology residency at Massachusetts Eye and Ear Infirmary/Harvard Medical School, and a fellowship at California Pacific Medical Center. He has experience in glaucoma, related disorders, and different forms of surgery. His professional career includes a long-standing position as an Adjunct Associate Professor at Nova Southeastern. Dr. Schacknow has published various works, primarily focusing on glaucoma. Among his honors and awards, he has been named in both Who's Who in Medicine and Healthcare and Guide to America's Top Physicians.
Education & Training
- California Pacific Medical CenterFellowship, Ophthalmology, 1987 - 1988
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1984 - 1987
- MetroWest Medical CenterInternship, Transitional Year, 1983 - 1984
- University of Miami Leonard M. Miller School of MedicineClass of 1983
- City University of New YorkPh.D., Experimental Psychology, 1970 - 1976
- Brooklyn CollegeB.S., Psychology, With Honors, 1965 - 1970
Certifications & Licensure
- FL State Medical License 1989 - 2026
- CA State Medical License 1987 - 2020
- MA State Medical License 1983 - 2009
- AL State Medical License 1988 - 2001
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- LEO Continuing Education Recognition Award American Academy of Ophthalmology, 2007
- Who's Who in Medicine and Healthcare - 6th Edition 2006
- Achievement Award American Academy of Ophthalmology, 2005
- Join now to see all
Publications & Presentations
PubMed
- 165 citationsA multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucomaPaul P. Lee, John G. Walt, John Doyle, Sameer Kotak, Stacy J. Evans
Archives of Ophthalmology. 2006-01-01 - 15 citationsTimolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hy...Douglas G. Day, Paul N. Schacknow, Martin Wand, Elizabeth D. Sharpe, Jeanette A. Stewart
American Journal of Ophthalmology. 2003-02-01 - Sudden Cardiac Death at Home: Potential Lives Saved With Fully Automated External Defibrillators.Lawrence J Gessman, Paul N Schacknow, Ralph G Brindis
Annals of Emergency Medicine. 2024-01-01
Journal Articles
- Association Between Intraocular Pressure Variation and Glaucoma Progression: Data from a United States Chart ReviewLee, PP et al. and the Glaucoma Care Study Group (including Schacknow, PN), American Journal of Ophthalmology, 1/1/2007
- Travoprost 0004% With And Without Benzalkonium Chloride: A Comparison Of Safety And EfficacyLewis, RA et al. and the Travoprost BAC-free Study Group (including Schacknow, PN), J of Glaucoma, 1/1/2007
- The Safety And Intraocular Pressure-Lowering Efficacy Of Brimonidine Tartrate 015% Preserved With Polyquaternium-1Whitson, J and the Brimonidine 0.15% Study Group (including Schacknow, PN), Ophthalmology, 1/1/2006
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Comparison of Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution And The Concomitant Administration Of Travatan And Timolol 0.5%Hughes, BA, et al, and the Travoprost 0.004% / Timolol 0.5% Study Group (including Schacknow, PN), Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, 1/28/2004
- Three Month Comparison Of The Safety And Efficacy Of Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution To Travatan And Timolol 0.5%Barnebey, HS, et al. and the Travoprost 0.004% / Timolol 0.5% Study Group (including Schacknow, PN), Association for Research in Vision and Ophthalmology, Annual Meeting, Fort Lauderdale, FL, 1/26/2004
- An Analysis Of The Intraocular Pressure Lowering Efficacy Of Travoprost In Patients On Multiple Therapy With Only A Fixed Combination Of Dorzolamide / Timolol Replaced.Pryzdryga, J, Schacknow, PN and the TRAVATAN START Study Group, 19th Congress of the Asia - Pacific Academy of Ophthalmology (APAO), Bangkok, Thailand, 1/29/2003
- Join now to see all
Lectures
- Glaucoma Management in the Age of GenericsPonce, Puerto Rico - 1/28/2011
- Ocular Surface Disease Prevalence Among Glaucoma PatientsEpic Hotel, Miami, FL - 1/24/2011
- A Comparison Of BAK-Free Glaucoma TherapiesEpic Hotel, Miami, FL - 1/24/2011
- Join now to see all
Other
- Prescribing Generics. (Expert interview)Schacknow, PN, Glaucoma Management, Vol.1 # 1, p. 13 (Vindico Medical Education)
Thorofare, NJ - 1/15/2011 - Topical CAIs are effective adjuncts to prostaglandins. (Telephone interview-article)Schacknow, PN, Ocular Surgery News (by Erin Boyle)
Thorofare, NJ - 1/15/2007 - Balancing Power and Control in Glaucoma TherapyCrandall, AS, Barneby, H, Cuneliffe, I, Miglior, S, Pryzdryga, J, Schacknow, PN, Teus, M, Ocular Surgery News, Europe/Asia-Pacific Edition
1/1/2003 - Join now to see all
Press Mentions
- Glaucoma 360 Reaches Milestones in Search of Glaucoma CureJanuary 29th, 2016
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: